Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C

NCT02640547 · clinicaltrials.gov ↗

COMPLETED

Status

394

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Sponsor

AbbVie

Collaborators

[object Object]